nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—MAOA—conduct disorder	0.552	0.608	CbGaD
Sertraline—SLC6A4—conduct disorder	0.356	0.392	CbGaD
Sertraline—MAOB—Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB—MAOA—conduct disorder	0.0139	0.153	CbGpPWpGaD
Sertraline—MAOA—Enzymatic degradation of Dopamine by monoamine oxidase—COMT—conduct disorder	0.00875	0.0965	CbGpPWpGaD
Sertraline—MAOB—Amine Oxidase reactions—MAOA—conduct disorder	0.00796	0.0877	CbGpPWpGaD
Sertraline—MAOA—Clearance of dopamine—COMT—conduct disorder	0.00633	0.0698	CbGpPWpGaD
Sertraline—SLC6A3—Clearance of dopamine—COMT—conduct disorder	0.00588	0.0649	CbGpPWpGaD
Sertraline—SLC6A3—Clearance of dopamine—MAOA—conduct disorder	0.00584	0.0644	CbGpPWpGaD
Sertraline—MAOB—Dopamine metabolism—COMT—conduct disorder	0.00312	0.0344	CbGpPWpGaD
Sertraline—MAOB—Dopamine metabolism—MAOA—conduct disorder	0.0031	0.0342	CbGpPWpGaD
Sertraline—MAOA—Serotonin Transporter Activity—SLC6A4—conduct disorder	0.00295	0.0326	CbGpPWpGaD
Sertraline—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.00289	0.0318	CbGpPWpGaD
Sertraline—SLC6A4—Serotonin Transporter Activity—MAOA—conduct disorder	0.00271	0.0299	CbGpPWpGaD
Sertraline—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.00268	0.0296	CbGpPWpGaD
Sertraline—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.00266	0.0294	CbGpPWpGaD
Sertraline—Maprotiline—HTR2A—conduct disorder	0.00225	1	CrCbGaD
Sertraline—MAOA—Dopamine metabolism—COMT—conduct disorder	0.00196	0.0216	CbGpPWpGaD
Sertraline—MAOA—Biogenic Amine Synthesis—COMT—conduct disorder	0.00175	0.0193	CbGpPWpGaD
Sertraline—SLC6A2—Monoamine Transport—SLC6A4—conduct disorder	0.00132	0.0145	CbGpPWpGaD
Sertraline—SLC6A3—Monoamine Transport—SLC6A4—conduct disorder	0.00117	0.0129	CbGpPWpGaD
Sertraline—CYP1A2—Methylation—COMT—conduct disorder	0.000891	0.00982	CbGpPWpGaD
Sertraline—MAOB—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000739	0.00815	CbGpPWpGaD
Sertraline—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.000557	0.00614	CbGpPWpGaD
Sertraline—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.000484	0.00534	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000457	0.00504	CbGpPWpGaD
Sertraline—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.000446	0.00491	CbGpPWpGaD
Sertraline—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00043	0.00474	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000425	0.00468	CbGpPWpGaD
Sertraline—MAOB—Biological oxidations—COMT—conduct disorder	0.000395	0.00436	CbGpPWpGaD
Sertraline—MAOB—Biological oxidations—MAOA—conduct disorder	0.000393	0.00433	CbGpPWpGaD
Sertraline—SLC6A2—NRF2 pathway—SLC6A4—conduct disorder	0.000392	0.00432	CbGpPWpGaD
Sertraline—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.000377	0.00416	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000354	0.0039	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—GABRA2—conduct disorder	0.00035	0.00386	CbGpPWpGaD
Sertraline—SLC6A3—NRF2 pathway—SLC6A4—conduct disorder	0.000347	0.00382	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—DRD4—conduct disorder	0.000331	0.00366	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—GABRA2—conduct disorder	0.000325	0.00359	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000325	0.00358	CbGpPWpGaD
Sertraline—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00029	0.0032	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000265	0.00292	CbGpPWpGaD
Sertraline—MAOA—Biological oxidations—COMT—conduct disorder	0.000248	0.00274	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—COMT—conduct disorder	0.00022	0.00242	CbGpPWpGaD
Sertraline—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000219	0.00242	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000217	0.00239	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—COMT—conduct disorder	0.000204	0.00225	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000203	0.00224	CbGpPWpGaD
Sertraline—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000202	0.00223	CbGpPWpGaD
Sertraline—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0002	0.00221	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000197	0.00218	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000175	0.00193	CbGpPWpGaD
Sertraline—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000171	0.00189	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—COMT—conduct disorder	0.000168	0.00186	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—COMT—conduct disorder	0.000157	0.00173	CbGpPWpGaD
Sertraline—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.000156	0.00172	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—MAOA—conduct disorder	0.000155	0.00171	CbGpPWpGaD
Sertraline—CYP2B6—Biological oxidations—COMT—conduct disorder	0.000155	0.00171	CbGpPWpGaD
Sertraline—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.000154	0.0017	CbGpPWpGaD
Sertraline—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.000153	0.00169	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CGA—conduct disorder	0.00015	0.00165	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00014	0.00155	CbGpPWpGaD
Sertraline—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000132	0.00146	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—COMT—conduct disorder	0.000117	0.00129	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.000117	0.00129	CbGpPWpGaD
Sertraline—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.000116	0.00128	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000115	0.00127	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—EP300—conduct disorder	0.000115	0.00126	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000113	0.00124	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.000113	0.00124	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—COMT—conduct disorder	0.000108	0.00119	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.000107	0.00118	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—COMT—conduct disorder	0.000107	0.00118	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.000107	0.00117	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.000106	0.00117	CbGpPWpGaD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.000106	0.00117	CbGpPWpGaD
Sertraline—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.000106	0.00116	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	9.99e-05	0.0011	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CGA—conduct disorder	9.4e-05	0.00104	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—COMT—conduct disorder	9.15e-05	0.00101	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	9.11e-05	0.001	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—MAOA—conduct disorder	9.08e-05	0.001	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	9.02e-05	0.000995	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	8.69e-05	0.000959	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	7.78e-05	0.000858	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—COMT—conduct disorder	7.06e-05	0.000779	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—MAOA—conduct disorder	7.01e-05	0.000773	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	6.96e-05	0.000768	CbGpPWpGaD
Sertraline—MAOB—Metabolism—COMT—conduct disorder	6.76e-05	0.000746	CbGpPWpGaD
Sertraline—MAOB—Metabolism—MAOA—conduct disorder	6.71e-05	0.00074	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CGA—conduct disorder	5.89e-05	0.000649	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	4.52e-05	0.000498	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CGA—conduct disorder	4.45e-05	0.000491	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CGA—conduct disorder	4.34e-05	0.000479	CbGpPWpGaD
Sertraline—MAOA—Metabolism—COMT—conduct disorder	4.24e-05	0.000468	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CGA—conduct disorder	4.09e-05	0.000451	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CGA—conduct disorder	4.06e-05	0.000447	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CGA—conduct disorder	3.47e-05	0.000382	CbGpPWpGaD
Sertraline—MAOB—Metabolism—EP300—conduct disorder	2.9e-05	0.00032	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CGA—conduct disorder	2.68e-05	0.000295	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—COMT—conduct disorder	2.66e-05	0.000293	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—MAOA—conduct disorder	2.64e-05	0.000291	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—COMT—conduct disorder	2.01e-05	0.000221	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—MAOA—conduct disorder	1.99e-05	0.00022	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—COMT—conduct disorder	1.96e-05	0.000216	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—MAOA—conduct disorder	1.95e-05	0.000215	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.93e-05	0.000213	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—COMT—conduct disorder	1.85e-05	0.000204	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—MAOA—conduct disorder	1.83e-05	0.000202	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—COMT—conduct disorder	1.83e-05	0.000202	CbGpPWpGaD
Sertraline—MAOA—Metabolism—EP300—conduct disorder	1.82e-05	0.000201	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—MAOA—conduct disorder	1.82e-05	0.0002	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.76e-05	0.000194	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—COMT—conduct disorder	1.56e-05	0.000173	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—MAOA—conduct disorder	1.55e-05	0.000171	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.51e-05	0.000166	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—COMT—conduct disorder	1.21e-05	0.000133	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—MAOA—conduct disorder	1.2e-05	0.000132	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—EP300—conduct disorder	1.14e-05	0.000126	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—EP300—conduct disorder	8.61e-06	9.5e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—EP300—conduct disorder	8.41e-06	9.27e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—EP300—conduct disorder	7.92e-06	8.73e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—EP300—conduct disorder	7.85e-06	8.66e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—EP300—conduct disorder	6.71e-06	7.4e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—EP300—conduct disorder	5.18e-06	5.71e-05	CbGpPWpGaD
